GGrantIndex
Sort

24,576 grants matching microbiome

Translational Epigenomics in Gastrointestinal Cancer

$199,549
Ming Yu · Fred Hutchinson Cancer Research Center · R50 · FY2020 · CA

Translational Epigenomics in Gastrointestinal Cancer

$199,549
Ming Yu · Fred Hutchinson Cancer Center · R50 · FY2022 · CA

Translational Epigenomics in Gastrointestinal Cancer

$199,549
Ming Yu · Fred Hutchinson Cancer Research Center · R50 · FY2018 · CA

Training Program in Immunology and Inflammation

$199,524
Joel D. Ernst · New York University School Of Medicine · T32 · FY2014 · AI

BBSRC-NSF/BIO:Collaborative Research: Phage host range evolution in spatially structured microbiomes

$199,508
William R Harcombe · University Of Minnesota-Twin Cities · · FY2020 · BIO

Genetics, glycemic control and the microbiome in cystic fibrosis

$199,507
Laura N Brenner · Massachusetts General Hospital · K23 · FY2021 · DK

Profiling diarrhea-predominant irritable bowel syndrome (IBS-D) using stool-based RNAs

$199,456
Harris H Wang · Columbia University Health Sciences · R21 · FY2025 · AI

Protein-protein interaction essential for bacterial growth and virulence

$199,390
Mark A Saper · University Of Michigan At Ann Arbor · R21 · FY2013 · AI

Fluorescence Lifetime Imaging (FLIm): a method to evaluate colon inflammation in vivo

$199,375
Alba Alfonso-Garcia · University Of California At Davis · R21 · FY2022 · DK

Bacteria-Virus interactions in genital herpes infections

$199,375
Smita Gopinath · Harvard University D/B/A Harvard School Of Public Health · R21 · FY2024 · AI

The SOS Response as a Generator of Antibiotic Resistance and Role of Zinc as SOS Inhibitor

$199,375
John K. Crane · State University Of New York At Buffalo · R21 · FY2020 · AI

Model of chemotherapy-induced mucositis

$199,375
Anna I Dongari-Bagtzoglou · University Of Connecticut Sch Of Med/Dnt · R21 · FY2015 · DE

Gut Microbiome and Pharmacokinetic Variability in Tuberculosis and Diabetes

$199,357
Navaneeth Narayanan · Rutgers, The State Univ Of N.J. · K23 · FY2022 · AI

Fungal-Bacterial Microbiome Interactions in the Developing Infant Gut

$199,300
Cheryl A Gale · University Of Minnesota · R21 · FY2019 · AI

Laboratory Sciences Core

$199,297
Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2024 · AI

Training Program in Molecular Metabolism

$199,284
Gokhan S Hotamisligil · Harvard School Of Public Health · T32 · FY2023 · DK

The Role of Enteric Infection in Flares of Inflammatory Bowel Disease

$199,260
Jordan Eric Axelrad · New York University School Of Medicine · K23 · FY2023 · DK

The Role of Enteric Infection in Flares of Inflammatory Bowel Disease

$199,260
Jordan Eric Axelrad · New York University School Of Medicine · K23 · FY2025 · DK

The Role of Enteric Infection in Flares of Inflammatory Bowel Disease

$199,260
Jordan Eric Axelrad · New York University School Of Medicine · K23 · FY2022 · DK

The Role of Enteric Infection in Flares of Inflammatory Bowel Disease

$199,260
Jordan Eric Axelrad · New York University School Of Medicine · K23 · FY2024 · DK

Core E: Laboratory and biobehavioral marker core

$199,148
Steven Daniel Douglas · University Of Pennsylvania · P30 · FY2020 · MH

The ocular surface microbiome in potentially infectious ophthalmic disease

$199,125
Cecilia Sungmin Lee · University Of Washington · K23 · FY2018 · EY

The ocular surface microbiome in potentially infectious ophthalmic disease

$199,125
Cecilia Sungmin Lee · University Of Washington · K23 · FY2019 · EY

The ocular surface microbiome in potentially infectious ophthalmic disease

$199,125
Cecilia Sungmin Lee · University Of Washington · K23 · FY2017 · EY

CATTLE ARE FREQUENTLY AFFECTED BY SERIOUS EYE DISEASES SUCH AS PINK EYE (INFECTIOUS BOVINE KERATOCONJUNCTIVITIS) AND CANCER (OCULAR SQUAMOUS CELL CARCINOMA). THESE DISEASES CAN SERIOUSLY AFFECT ANIMAL WELFARE AND CAUSE ECONOMIC BURDEN TO PRODUCERS. WE BELIEVE THAT CATTLE WILL HAVE UNDERLYING ALTERATIONS IN THE GROUPS OF BACTERIA ON THE SURFACE OF THE EYE WHEN THESE ANIMALS HAVE PINK EYE OR EYE CANCER. BY UNDERSTANDING THESE BACTERIAL ALTERATIONS WE HOPE TO BE ABLE TO DEVELOP NEW TREATMENTS FOR THESE DISEASES. WE ARE GOING TO USE AN ADVANCED TECHNIQUE CALLED 16S NEXT-GENERATION MICROBIOME SEQUENCING TO DETECT AND QUANTIFY THESE BACTERIAL GROUPS IN NORMAL ANIMALS AND ANIMALS WITH EYE CANCER OR PINK EYE. WE EXPECT THAT WE WILL IDENTIFY GROUPS OF BACTERIA WHICH ARE PRESENT OR ABSENT IN THESE DISEASED EYES AND THAT THIS NEW INFORMATION COULD HELP FORM THE BASIS OF NEW TREATMENTS - POTENTIALLY WITHOUT THE USE OF ANTIBIOTICS. THIS WORK IS VERY IMPORTANT BECAUSE IT IS CURRENTLY UNKNOWN HOW THESE COMMON EYE DISEASES AFFECT THE BACTERIA ON THE SURFACE OF THE EYE AND AVAILABLE EFFECTIVE TREATMENTS ARE LACKING. BY UNDERSTANDING THESE CHANGES IN ANIMALS WITH EYE DISEASE, NEW TREATMENTS COULD BECOME AVAILABLE FOR BOTH PINK EYE AND EYE CANCER IN CATTLE.

$199,054
Louisiana State University · · FY2020 · National Institute of Food and Agriculture